Global POC Blood Glucose Monitoring Devices Market 2017-2021
- SKU ID : TNV-IRTNTR14242 11107331
- |
- Publishing Date: 08-Sep-2017
- |
- Region: Global
- |
- No. of pages: 90
About POC Blood Glucose Monitoring Devices
POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools. The global POC blood glucose monitoring devices market is in its growing stage. A paradigm shift toward minimally invasive procedures for the screening of blood glucose level is increasing the demand for POC blood glucose monitoring devices in the market.
Technavio’s analysts forecast the global POC blood glucose monitoring devices market to grow at a CAGR of 8.16% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2017-2021. To calculate the market size, the report considers sales, volume, value of POC blood glucose monitoring devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global POC Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere
• F. Hoffmann-La Roche
• LifeScan
Other prominent vendors
• AgaMatrix
• Menarini Diagnostics
• Animas
• Ascensia Diabetes Care
• Bayer Healthcare
• BD
• BIOPTIK
• DarioHealth
• DexCom
• EKF Diagnostics
• GlySens
• HemoCue
• Integrity Applications
• International Biomedical
• Medisana
• MediWise
• Nemaura
• Nipro
• Nova Biomedical
• Omnis Health
• Owen Mumford
• Philips Healthcare
• Randox Laboratories
• Senseonics
• TaiDoc Technology
Market driver
• Availability of CGMS and SMBG systems for POC blood glucose monitoring
• For a full, detailed list, view our report
Market challenge
• High cost of diabetes management
• For a full, detailed list, view our report
Market trend
• Growing adoption of minimally invasive and technologically superior products
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools. The global POC blood glucose monitoring devices market is in its growing stage. A paradigm shift toward minimally invasive procedures for the screening of blood glucose level is increasing the demand for POC blood glucose monitoring devices in the market.
Technavio’s analysts forecast the global POC blood glucose monitoring devices market to grow at a CAGR of 8.16% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2017-2021. To calculate the market size, the report considers sales, volume, value of POC blood glucose monitoring devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global POC Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere
• F. Hoffmann-La Roche
• LifeScan
Other prominent vendors
• AgaMatrix
• Menarini Diagnostics
• Animas
• Ascensia Diabetes Care
• Bayer Healthcare
• BD
• BIOPTIK
• DarioHealth
• DexCom
• EKF Diagnostics
• GlySens
• HemoCue
• Integrity Applications
• International Biomedical
• Medisana
• MediWise
• Nemaura
• Nipro
• Nova Biomedical
• Omnis Health
• Owen Mumford
• Philips Healthcare
• Randox Laboratories
• Senseonics
• TaiDoc Technology
Market driver
• Availability of CGMS and SMBG systems for POC blood glucose monitoring
• For a full, detailed list, view our report
Market challenge
• High cost of diabetes management
• For a full, detailed list, view our report
Market trend
• Growing adoption of minimally invasive and technologically superior products
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
